Join the 200th Anniversary Celebration

Original Article

The Prognostic Value of a Nomogram for Exercise Capacity in Women

Martha Gulati, M.D., Henry R. Black, M.D., Leslee J. Shaw, Ph.D., Morton F. Arnsdorf, M.D., C. Noel Bairey Merz, M.D., Michael S. Lauer, M.D., Thomas H. Marwick, M.D., Ph.D., Dilip K. Pandey, Ph.D., Roxanne H. Wicklund, R.N., and Ronald A. Thisted, Ph.D.

N Engl J Med 2005; 353:468-475August 4, 2005

Abstract

Background

Recent studies have demonstrated that exercise capacity is an independent predictor of mortality in women. Normative values of exercise capacity for age in women have not been well established. Our objectives were to construct a nomogram to permit determination of predicted exercise capacity for age in women and to assess the predictive value of the nomogram with respect to survival.

Methods

A total of 5721 asymptomatic women underwent a symptom-limited, maximal stress test. Exercise capacity was measured in metabolic equivalents (MET). Linear regression was used to estimate the mean MET achieved for age. A nomogram was established to allow the percentage of predicted exercise capacity to be estimated on the basis of age and the exercise capacity achieved. The nomogram was then used to determine the percentage of predicted exercise capacity for both the original cohort and a referral population of 4471 women with cardiovascular symptoms who underwent a symptom-limited stress test. Survival data were obtained for both cohorts, and Cox survival analysis was used to estimate the rates of death from any cause and from cardiac causes in each group.

Results

The linear regression equation for predicted exercise capacity (in MET) on the basis of age in the cohort of asymptomatic women was as follows: predicted MET = 14.7 – (0.13 × age). The risk of death among asymptomatic women whose exercise capacity was less than 85 percent of the predicted value for age was twice that among women whose exercise capacity was at least 85 percent of the age-predicted value (P<0.001). Results were similar in the cohort of symptomatic women.

Conclusions

We have established a nomogram for predicted exercise capacity on the basis of age that is predictive of survival among both asymptomatic and symptomatic women. These findings could be incorporated into the interpretation of exercise stress tests, providing additional prognostic information for risk stratification.

Media in This Article

Figure 1Nomogram of the Percentage of Predicted Exercise Capacity for Age in Asymptomatic Men and Women.
Figure 2Nomogram of the Percentage of Predicted Exercise Capacity for Age in Sedentary and Active Women in the Asymptomatic Cohort.
Article

Exercise capacity is an independent predictor of the risk of death and cardiac events among asymptomatic women and men.1-5 Exercise capacity may be defined as the maximal oxygen uptake for a given workload6,7 and can be expressed in metabolic equivalents (MET), or multiples of the basal rate of oxygen consumption when a person is at rest (3.5 ml per kilogram of body weight per minute for an average adult).8 Exercise capacity can be estimated by performing a symptom-limited stress test.

Exercise capacity varies with age, sex, and health. A number of studies have established that there is a negative linear relationship between exercise capacity and age in men, and a nomogram has been developed for men that estimates the percentage of predicted exercise capacity for a given age.6,7,9-11 Few studies have evaluated exercise capacity in women, and to date, no standard for age-related declines in physical fitness has been established for women.

We had two goals in conducting this study. The first was to create a simple nomogram for women to allow the conversion of the MET value achieved on a stress test into a percentage of the predicted exercise capacity for any age, on the basis of findings in a population of asymptomatic women. The second goal was to assess the usefulness of the nomogram in predicting survival among both asymptomatic women and a referral population of women with cardiovascular symptoms in order to determine its usefulness in clinical practice.

Methods

Asymptomatic Population

The asymptomatic population came from the St. James Women Take Heart Project. This cohort has previously been described.1 Briefly, in 1992 volunteers were solicited from the Chicago metropolitan area to participate in a study of heart disease in women. The project was approved by the institutional review board of St. James Hospital and Rush–Presbyterian–St. Luke's Medical Center, with written informed consent obtained from all study participants.

Inclusion criteria for the study cohort were an age of at least 35 years and the ability to walk on a treadmill at a moderate pace. Women were excluded if they were pregnant, had typical anginal symptoms or any history of cardiac disease (including previous myocardial infarction, documented coronary artery disease, heart failure, or valvular heart disease), weighed more than 148 kg (325 lb), had a baseline blood pressure of 170/110 mm Hg or higher, or had incomplete data concerning cardiac risk factors. Members of the cohort were classified as sedentary or active on the basis of their response to one question: Do you have a regular (exercise) training program?

Referral Population

The referral population came from the Economics of Noninvasive Diagnosis Study, which has been described previously.12,13 Briefly, this cohort was composed of consecutive women from six medical centers who were referred between 1990 and 1995 for a symptom-limited exercise stress test with the use of the Bruce protocol14 for the evaluation of suspected coronary disease. Women were excluded if they had recently been hospitalized for unstable angina, myocardial infarction, or coronary revascularization. The study was approved by the institutional review board at each of the six participating centers. For all but one site, written informed consent for follow-up was obtained at the time of the initial procedure. For the remaining site, the requirement for informed consent was waived by the institutional review board because the data were from a previously approved database.

Exercise Treadmill Testing

All participants underwent a symptom-limited treadmill test according to the Bruce protocol.14 The test was discontinued in the event of limiting symptoms (angina, dyspnea, or fatigue), abnormalities of rhythm or blood pressure, or marked and progressive ST-segment deviation. Target heart rates were not used as a predetermined end point.

In the asymptomatic group, some participants underwent stress testing according to a modified Bruce protocol. These women were excluded from the analysis, because submaximal exercise testing does not accurately reflect physical fitness in the way that maximal exercise testing does.

Exercise Capacity

The estimated exercise capacity was measured in MET6,7 as defined above. The estimate was based on the speed and grade of the treadmill.15

Follow-up Data

The number of deaths from any cause in the asymptomatic cohort was determined by searching the National Death Index to identify deaths and causes of death from the time of the baseline evaluation in 1992 through the end of 2000. Follow-up information was obtained on the referral (symptomatic) population through 2000 during a clinic visit or telephone interview. Deaths were identified and the cause of death was classified after a review of death certificates by an independent reviewer who was unaware of the women's clinical history and stress-testing data.

Statistical Analysis

The MET achieved was determined from the final speed and grade of the treadmill, as defined for the Bruce protocol.15 Using the asymptomatic population, we calculated the linear regression of exercise capacity (in MET) on age; no evidence of nonlinearity was found. The calculated value from the regression equation for age was defined as 100 percent of the age-predicted exercise capacity.

For each participant in both groups, the percentage of the predicted exercise capacity achieved for age was then calculated with the use of the following equation: percentage of predicted exercise capacity achieved for age = (observed MET ÷ age-predicted MET) × 100. A nomogram to determine the percentage of predicted exercise capacity for age was constructed with the use of the linear regression equation for the asymptomatic cohort. Similarly, separate nomograms were also created for both the active and sedentary groups.

The correlation of the percentage of predicted exercise capacity for any given age with subsequent survival was calculated in both groups. The rates of death from any cause and from cardiac causes were analyzed for both populations with the use of univariate Cox proportional-hazards models, on the basis of the deviation from the predicted normal value of exercise capacity for age. From the Cox models, the predicted rates of death from cardiac causes were plotted against the ratio of observed exercise capacity to expected exercise capacity, and an r2 statistic was calculated. Annualized death rates and rates of death from cardiac causes were calculated by dividing the predicted death rates from the Cox model by the length of follow-up. All analyses were performed with the use of STATA software (version 8.0) or SPSS software (version 12.0). A two-sided P value of less than 0.05 was considered to indicate statistical significance.

Results

A total of 5721 asymptomatic women and 4471 symptomatic women met the study-specific inclusion criteria.1,12,13,16 The characteristics of the two cohorts are shown in Table 1Table 1Characteristics of the Study Cohorts.. The asymptomatic cohort was younger than the symptomatic cohort and was predominantly white (85 percent). Although the majority of the symptomatic women were white, almost a third were black. Fewer asymptomatic women had a history of hypertension or diabetes. Atypical symptoms accounted for only a quarter of the symptoms in the symptomatic cohort. The asymptomatic women had a higher mean exercise capacity and a lower overall mortality rate during the follow-up period than did the symptomatic women.

Predicted Exercise Capacity

The relationship between exercise capacity and age in the cohort of 5721 asymptomatic women was linear. Regression analysis of exercise capacity for age yielded the following equation: predicted MET = 14.7 – (0.13 × age), with an age-adjusted SD of 2.3 (r=–0.51, P<0.001).

The same regression analysis was stratified according to the level of reported activity. A total of 212 women did not respond to the exercise question and were excluded from this analysis. For the active subgroup of 866 women, the regression equation was as follows: predicted MET = 17.9 – (0.16 × age), with an age-adjusted SD of 2.4 (r=–0.59, P<0.001). For the sedentary subgroup of 4643 women, the regression equation was as follows: predicted MET = 14.0 – (0.12 × age), with an age-adjusted SD of 2.2 (r=–0.49, P<0.001).

The nomogram for the entire asymptomatic population (the first equation) is shown in Figure 1Figure 1Nomogram of the Percentage of Predicted Exercise Capacity for Age in Asymptomatic Men and Women., with the previously reported nomogram for asymptomatic men provided for comparison.6 The nomograms based on self-reported activity level (from the second and third equations) are shown in Figure 2Figure 2Nomogram of the Percentage of Predicted Exercise Capacity for Age in Sedentary and Active Women in the Asymptomatic Cohort.. The active women had a greater predicted exercise capacity for any given age than their more sedentary counterparts.

Using the first regression equation to predict normal exercise capacity for age and the equation for the percentage of predicted exercise capacity achieved for age, we determined the percentage of predicted exercise capacity achieved for each participant in both populations. The results ranged from 20 percent to 150 percent of the predicted value for age.

Exercise Capacity and Prognosis

In the asymptomatic cohort, there were 180 deaths overall (3 percent) and 58 deaths from cardiac causes (1 percent) during a mean follow-up of 8.4 years (Table 1). Women in this cohort were assumed to be alive if they were not identified as having died by a search of the National Death Index. In the symptomatic cohort, there were 537 deaths overall (12 percent) and 45 deaths from cardiac causes (1 percent) during a mean follow-up of 5.3 years (Table 1); 3 percent of this cohort was lost to follow-up.

In the asymptomatic cohort, the women whose exercise capacity was less than 85 percent of the age-predicted value had a hazard ratio for death from any cause of 2.03 (P<0.001) and a hazard ratio for death from cardiac causes of 2.44 (P<0.001), as compared with the women whose exercise capacity was at least 85 percent of the age-predicted value (Table 2Table 2Hazard Ratios for Death from Any Cause and from Cardiac Causes among Women, According to the Deviation from the Expected Exercise Capacity for Age.). In the asymptomatic cohort, as compared with women whose exercise capacity exceeded the age-predicted value by more than 3 MET, women whose exercise capacity was less than that predicted for age (for whom the observed exercise capacity minus the predicted exercise capacity was less than 0 MET) had a hazard ratio for death from any cause of 2.63 (P=0.005) and for death from cardiac causes of 4.27 (P=0.045) (Table 2). The amount of deviation from one's age-predicted exercise capacity was correlated with the risk of both death from any cause and death from cardiac causes.

In the symptomatic population, as compared with the women whose exercise capacity was at least 85 percent of the age-predicted value, women whose exercise capacity was less than 85 percent of the age-predicted value had a hazard ratio for death from any cause of 2.37 (P<0.001) and for death from cardiac causes of 2.02 (P<0.001) (Table 2). As compared with women whose exercise capacity exceeded the age-predicted value by more than 3 MET, women whose exercise capacity was less than that predicted for age (i.e., a deviation of less than 0 MET) had a hazard ratio for death from any cause of 3.28 (P<0.001) and for death from cardiac causes of 3.80 (P<0.001) (Table 2). The relationship between exercise capacity and the risk of death from cardiac causes was remarkably similar for all age groups in the symptomatic cohort, with two exceptions. Young women (less than 55 years of age) with a poor exercise capacity (for whom the observed exercise capacity minus the predicted exercise capacity was less than –2 MET) had an especially high mortality rate, as did the oldest women (older than 70 years) for whom the observed exercise capacity minus the predicted exercise capacity was less than 1 MET (Figure 3Figure 3Rate of Death from Cardiac Causes as a Function of the Deviation from the Expected Exercise Capacity for Age among Symptomatic Women.).

Use of the Nomogram

Use of the nomogram for the percentage of predicted exercise capacity for age (Figure 1) requires only the woman's age and exercise capacity achieved (in MET) on the exercise stress test. Drawing a straight line between the age and exercise capacity will allow the determination of the percentage of predicted exercise capacity for age; a value of 100 percent is the mean for any given age. Any result greater than 100 percent indicates better-than-average performance. Any result lower than 100 percent indicates some degree of functional impairment for age. For example, a 60-year-old woman whose exercise capacity was 7 MET on a Bruce-protocol exercise test would have achieved 100 percent of the predicted exercise capacity for her age. In contrast, a 35-year-old woman whose exercise capacity was also 7 MET would have achieved 69 percent of her age-predicted exercise capacity.

Discussion

The first goal of this study was to define the mean age-predicted exercise capacity for women, as depicted by the nomogram in Figure 1. Although such a nomogram has been established for men and is routinely used in clinical practice, no such nomogram has been established for women, nor have the previous findings in men been validated in the female population.

A number of regression equations for predicting exercise capacity in a variety of male populations have been described.6,7,9-11 Three of these studies examined the relationship of exercise capacity to age in healthy men.6,7,9 For the asymptomatic women in our study, the regression equation for predicting exercise capacity for age was similar to the regression equations established for healthy men.6,7,9 In particular, it was very similar to the equation derived from the 244 healthy men in the study by Morris et al.6: predicted MET = 14.7 – (0.11 × age), with an age-adjusted SD of 2.5 (r=–0.53, P<0.001). Both equations for asymptomatic men and women share the same constant in the regression equation, and the coefficient differs by only 0.02. Although this number appears small at first glance, the coefficient is multiplied by age. This means that the difference in the predicted exercise capacity for age between men and women will increase as age increases. The nomograms for men and women, when shown side by side, clearly demonstrate the difference between the sexes (Figure 1).

Within our cohort of asymptomatic women, the regression equation differed on the basis of self-reported physical-activity status. Women were classified as either sedentary or active, on the basis of one question regarding their participation in a regular activity program. Although the validity of this question has not been established, we have shown a difference in achieved exercise capacity for any age group on the basis of activity status; the more physically active women had a greater exercise capacity at all ages.

The nomogram developed in the cohort of asymptomatic women was also used to determine the percentage of predicted exercise capacity in a referral cohort of racially diverse women from six institutions. Deviation from the established normal values was a significant predictor of the risk of death from any cause and from cardiac causes in both the symptomatic and asymptomatic groups. The further the deviation below the predicted normative value, the greater the risk of death.

The use of the women's nomogram results in a more accurate assessment of prognosis among the women than does the use of the men's nomogram in this group. The sensitivity and specificity of our survival model for predicting the risk of death from any cause among the asymptomatic women are 70 percent and 47 percent, respectively, when the women's nomogram is used. In contrast, the sensitivity and specificity are 55 percent and 64 percent, respectively, when the men's nomogram is used. Use of the men's nomogram in our cohort would have resulted in 800 more false positive results as compared with the 30 fewer false negative results.

The chief limitation of our study is that the nomogram was created from data on a volunteer cohort of asymptomatic, mostly white women. The referral population differed from the asymptomatic cohort. Traditional cardiac risk factors were expected to be more prevalent in the symptomatic population than in the asymptomatic population, and indeed, these women were older and were more likely to have hypertension and diabetes. The symptomatic women were also more racially diverse, with a stronger representation of black women. Prior studies have suggested that clinicians should use a nomogram for the particular population from which it was created. However, the nomogram we have developed was predictive of the risk of death in the symptomatic group, with hazard ratios similar to those in the asymptomatic group from which it was derived. Whether another nomogram derived from a symptomatic cohort or from a population with more black women would be a better predictor of the risk of death in our referral cohort is open to question. Such an approach could, however, imply the need for a different nomogram for every clinical population tested, an approach that is not likely to be practical and that might in any case result in findings not very different from ours.

We estimated exercise capacity on the basis of the speed and degree of incline of the treadmill. In contrast, in the study by Morris et al., ventilatory gas exchange was measured directly in asymptomatic men during the stress test.6 This distinction is important, since determination of MET levels from a stress test has been demonstrated to overestimate the exercise capacity.17-19 If oxygen consumption had been measured directly in our study population, the nomograms for men and women would presumably have differed even more.

Despite extensive research on the role of exercise stress testing and exercise capacity, there has been a paucity of data on women, particularly asymptomatic women. Thus, what is normal or expected for healthy women has not been well established. We have developed a nomogram for women that can be used to predict a woman's expected exercise capacity at any given age and have demonstrated that the resulting measure is a predictor of the risk of death in both asymptomatic and symptomatic cohorts.

Supported by grants from AstraZeneca, DuPont Pharmaceuticals, the Irwin Foundation, Merck, Pfizer/Pharmacia, Siemans Gammasonics, and St. James Hospital and Health Centers (Chicago Heights, Ill.).

Drs. Gulati and Thisted have a patent pending for the nomogram described in this article. The rights to this patent are owned by Rush University Medical Center and the University of Chicago. Dr. Arnsdorf reports being paid for his role as co-editor-in-chief (cardiovascular medicine) at UpToDate. Dr. Merz reports having received consulting fees from Pfizer, Bayer, Fujisawa, and Merck; lecture fees from Pfizer, AM Medica Communications, Merck, and KOS Pharmaceuticals; and medical-education grants from Pfizer, Wyeth, Procter & Gamble, Novartis, AstraZeneca, and Bristol-Myers Squibb and owning stock in Boston Scientific, IVAX, Lilly, Medtronic, Johnson & Johnson, SCIPIE Insurance, ATS Medical, and Biosite.

This article is dedicated to the memory of Dr. Arfan Al-Hani, who designed the St. James Women Take Heart Project. Without his foresight, enthusiasm, and dedication, this study would not exist.

We are indebted to the participants of the St. James Women Take Heart Project and the Economics of Noninvasive Diagnosis Study Group.

Source Information

From the Department of Preventive Medicine, Rush University Medical Center, Chicago (M.G., H.R.B.); the Division of Cardiology, Department of Medicine, Cedars–Sinai Research Institute, Cedars–Sinai Medical Center, Los Angeles (L.J.S., C.N.B.M.); the Departments of Medicine (M.F.A.) and Health Studies (R.A.T.), University of Chicago, Chicago; the Department of Cardiology, Cleveland Clinic Foundation, Cleveland (M.S.L.); the Department of Medicine, Princess Alexandra Hospital, Brisbane, Australia (T.H.M.); the Department of Neurology, University of Illinois, Chicago (D.K.P.); and the Division of Cardiology, St. James Hospital and Health Centers, Chicago Heights, Ill. (R.H.W.).

Address reprint requests to Dr. Gulati at Northwestern University, Bluhm Cardiovascular Institute, 201 E. Huron St., Chicago, IL 60611, or at .

References

References

  1. 1

    Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 2003;108:1554-1559
    CrossRef | Web of Science | Medline

  2. 2

    Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the Lipid Research Clinics Prevalence Study. JAMA 2003;290:1600-1607
    CrossRef | Web of Science | Medline

  3. 3

    Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 1989;262:2395-2401
    CrossRef | Web of Science | Medline

  4. 4

    Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men: the Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988;319:1379-1384
    Full Text | Web of Science | Medline

  5. 5

    Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999;282:1547-1553
    CrossRef | Web of Science | Medline

  6. 6

    Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 1993;22:175-182
    CrossRef | Web of Science | Medline

  7. 7

    Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:546-562
    CrossRef | Web of Science | Medline

  8. 8

    Jette M, Sidney K, Blumchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol 1990;13:555-565
    CrossRef | Web of Science | Medline

  9. 9

    Froelicher VF Jr, Allen M, Lancaster MC. Maximal treadmill testing of normal USAF aircrewmen. Aerosp Med 1974;45:310-315
    Medline

  10. 10

    Dehn MM, Bruce RA. Longitudinal variations in maximal oxygen intake with age and activity. J Appl Physiol 1972;33:805-807
    Web of Science | Medline

  11. 11

    Wolthuis RA, Froelicher VF Jr, Fischer J, Triebwasser JH. The response of healthy men to treadmill exercise. Circulation 1977;55:153-157
    Web of Science | Medline

  12. 12

    Marwick TH, Shaw LJ, Lauer MS, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Am J Med 1999;106:172-178
    CrossRef | Web of Science | Medline

  13. 13

    Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation 2001;103:2566-2571
    Web of Science | Medline

  14. 14

    Bruce RA. Exercise testing of patients with coronary heart disease: principles and normal standards for evaluation. Ann Clin Res 1971;3:323-332
    Medline

  15. 15

    Foster C, Jackson AS, Pollock ML, et al. Generalized equations for predicting functional capacity from treadmill performance. Am Heart J 1984;107:1229-1234
    CrossRef | Web of Science | Medline

  16. 16

    Shaw LJ, Hendel R, Cerquiera M, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;45:1494-1504
    CrossRef | Web of Science | Medline

  17. 17

    Myers J, Buchanan N, Walsh D, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991;17:1334-1342
    CrossRef | Web of Science | Medline

  18. 18

    Sullivan M, McKirnan MD. Errors in predicting functional capacity for postmyocardial infarction patients using a modified Bruce protocol. Am Heart J 1984;107:486-492
    CrossRef | Web of Science | Medline

  19. 19

    Roberts JM, Sullivan M, Froelicher VF, Genter F, Myers J. Predicting oxygen uptake from treadmill testing in normal subjects and coronary artery disease patients. Am Heart J 1984;108:1454-1460
    CrossRef | Web of Science | Medline

Citing Articles (75)

Citing Articles

  1. 1

    Massimo Venturelli, Federico Schena, Renato Scarsini, Ettore Muti, Russell S. Richardson. (2012) Limitations to exercise in female centenarians: evidence that muscular efficiency tempers the impact of failing lungs. AGE
    CrossRef

  2. 2

    Ugo Corrà, Alessandro Mezzani, Andrea Giordano, Massimo Pistono, Marco Gnemmi, Roberto Caruso, Pantaleo Giannuzzi. (2012) Peak oxygen consumption and prognosis in heart failure. International Journal of Cardiology
    CrossRef

  3. 3

    Lowie E.G.W. Vanfleteren, Frits M.E. Franssen, Nicole H.M.K. Uszko-Lencer, Martijn A. Spruit, Mieke Celis, Anton P. Gorgels, Emiel F.M. Wouters. (2011) Frequency and Relevance of Ischemic Electrocardiographic Findings in Patients With Chronic Obstructive Pulmonary Disease. The American Journal of Cardiology 108:11, 1669-1674
    CrossRef

  4. 4

    Angela S. Koh, Ron Blankstein. (2011) Selecting the Best Noninvasive Imaging Test to Guide Treatment After an Inconclusive Exercise Test. Current Treatment Options in Cardiovascular Medicine
    CrossRef

  5. 5

    Chih-Hsin Hsu, Cherylanne Glassner, Aimee J. Foreman, Richa Agarwal, Raymond J. Benza, Robert P. Frantz, Mardi Gomberg-Maitland. (2011) Treadmill testing improves survival prediction models in pulmonary arterial hypertension. American Heart Journal
    CrossRef

  6. 6

    Lawrence Phillips, Jing Wa Wang, Brad Pfeffer, Eugenia Gianos, Daniel Fisher, Leslee J. Shaw, Jennifer H. Mieres. (2011) Clinical role of the Duke Activity Status Index in the selection of the optimal type of stress myocardial perfusion imaging study in patients with known or suspected ischemic heart disease. Journal of Nuclear Cardiology
    CrossRef

  7. 7

    Stefan De Hert, Georgina Imberger, John Carlisle, Pierre Diemunsch, Gerhard Fritsch, Iain Moppett, Maurizio Solca, Sven Staender, Frank Wappler, Andrew Smith. (2011) Preoperative evaluation of the adult patient undergoing non-cardiac surgery. European Journal of Anaesthesiology 28:10, 684-722
    CrossRef

  8. 8

    Jennifer H. Mieres, Gary V. Heller, Robert C. Hendel, Martha Gulati, William E. Boden, Deborah Katten, Leslee J. Shaw. (2011) Signs and Symptoms of Suspected Myocardial Ischemia in Women: Results from the What is the Optimal Method for Ischemia Evaluation in WomeN? Trial. Journal of Women's Health 20:9, 1261-1268
    CrossRef

  9. 9

    Laura M. Gaydos, Paula R. Pullen, Carol J.R. Hogue, Vanessa Elliott, Cheryl Goffney Franklin. (2011) Calculated Metabolic Equivalents: A Tool for Exercise Prescription Among African American Women. Journal of Women's Health 20:8, 1151-1155
    CrossRef

  10. 10

    David J Holland, Julian W Sacre, Rodel L Leano, Thomas H Marwick, James E Sharman. (2011) Contribution of abnormal central blood pressure to left ventricular filling pressure during exercise in patients with heart failure and preserved ejection fraction. Journal of Hypertension 29:7, 1422-1430
    CrossRef

  11. 11

    Stacie L. Daugherty, David J. Magid, Jennifer R. Kikla, John E. Hokanson, Judith Baxter, Colleen A. Ross, Frederick A. Masoudi. (2011) Gender differences in the prognostic value of exercise treadmill test characteristics. American Heart Journal 161:5, 908-914
    CrossRef

  12. 12

    M. Baudet, C. Daugareil, J. Ferrieres. (2011) Prévention des maladies cardiovasculaires et règles hygiéno-diététiques. Annales de Cardiologie et d'Angéiologie
    CrossRef

  13. 13

    Dongdong Zhao, Yong Wang, Yidong Wei, Kai Tang, XueJing Yu, Yawei Xu. (2011) QT restitution properties of middle-aged women with different exercise capacities. Journal of Electrocardiology 44:3, 340-345
    CrossRef

  14. 14

    Håkan Kronander, Niklas Hammar, Werner Fischer-Colbrie, Jacek Nowak, Lars-Åke Brodin, Håkan Elmqvist. (2011) Analysis of ST/HR hysteresis improves long-term prognostic value of exercise ECG test. International Journal of Cardiology 148:1, 64-69
    CrossRef

  15. 15

    C Noel Bairey Merz, Leslee J Shaw. (2011) Stable angina in women: lessons from the National Heart, Lung and Blood Institute-sponsored Womenʼs Ischemia Syndrome Evaluation. Journal of Cardiovascular Medicine 12:2, 85-87
    CrossRef

  16. 16

    Mary H. Zhang, Beeya Na, Nelson B. Schiller, Mary A. Whooley. (2010) Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: Data from the Heart and Soul study. Atherosclerosis 213:2, 604-610
    CrossRef

  17. 17

    Lee W. Jones, Jeffrey Peppercorn, Jessica M. Scott, Claudio Battaglini. (2010) Erratum to: Exercise Therapy in the Management of Solid Tumors. Current Treatment Options in Oncology 11:3-4, 73-86
    CrossRef

  18. 18

    Alfredo Jose Mansur, Rafael Amorim Belo Nunes. (2010) Heart rate response and chronotropic incompetence in exercise stress testing of asymptomatic women. Women's Health 6:6, 785-787
    CrossRef

  19. 19

    Andrew Friedrich, Tarek Helmy. (2010) Prevention of Perioperative Myocardial Infarction. International Anesthesiology Clinics 47:4, 13-36
    CrossRef

  20. 20

    Scott E. McIntosh, Marion McDevitt, George W. Rodway, Jennifer Dow, Colin K. Grissom. (2010) Demographic, Geographic, and Expedition Determinants of Reaching the Summit of Denali. High Altitude Medicine & Biology 11:3, 223-229
    CrossRef

  21. 21

    J. Abdulnour, P. Boulay, M. Brochu, R. Rabasa-Lhoret, S. Yasari, D. Prud'homme. (2010) Relationship between the percentage of predicted cardiorespiratory fitness and cardiovascular disease risk factors in premenopausal women: a MONET study. Climacteric 13:4, 347-354
    CrossRef

  22. 22

    Samuele Maria Marcora, Walter Staiano. (2010) The limit to exercise tolerance in humans: mind over muscle?. European Journal of Applied Physiology 109:4, 763-770
    CrossRef

  23. 23

    Lee W. Jones, Jeffrey Peppercorn, Jessica M. Scott, Claudio Battaglini. (2010) Exercise Therapy in the Management of Solid Tumors. Current Treatment Options in Oncology 11:1-2, 45-58
    CrossRef

  24. 24

    Ross Arena, Jonathan Myers, Marco Guazzi. (2010) The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign?. Future Cardiology 6:3, 325-342
    CrossRef

  25. 25

    Lawrence M. Phillips, Jennifer H. Mieres. (2010) Noninvasive Assessment of Coronary Artery Disease in Women: What’s Next?. Current Cardiology Reports 12:2, 147-154
    CrossRef

  26. 26

    Bredy Pierre-Louis, Wilbert S. Aronow, Joo H. Yoon, Chul Ahn, Albert J. DeLuca, Melvin B. Weiss, Kumar Kalapatapu, Anthony L. Pucillo, Craig E. Monsen. (2010) Incidence of Myocardial Infarction or Stroke or Death at 47-Month Follow-Up in Patients With Diabetes and a Predicted Exercise Capacity â¤85% vs >85% During an Exercise Treadmill Sestamibi Stress Test. Preventive Cardiology 13:1, 14-17
    CrossRef

  27. 27

    Sharlene M. Day. (2009) Exercise in Hypertrophic Cardiomyopathy. Journal of Cardiovascular Translational Research 2:4, 407-414
    CrossRef

  28. 28

    Leslee J. Shaw, Raffaelle Bugiardini, C. Noel Bairey Merz. (2009) Women and Ischemic Heart Disease. Journal of the American College of Cardiology 54:17, 1561-1575
    CrossRef

  29. 29

    , Stefan Möhlenkamp, Nils Lehmann, Axel Schmermund, Ulla Roggenbuck, Susanne Moebus, Nico Dragano, Marcus Bauer, Hagen Kälsch, Barbara Hoffmann, Andreas Stang, Martina Bröcker-Preuss, Michael Böhm, Klaus Mann, Karl-Heinz Jöckel, Raimund Erbel. (2009) Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study. Clinical Research in Cardiology 98:10, 665-676
    CrossRef

  30. 30

    Lee W. Jones, Neil D. Eves, Emily Waner, Anil A. Joy. (2009) Exercise therapy across the lung cancer continuum. Current Oncology Reports 11:4, 255-262
    CrossRef

  31. 31

    E. M. Hazel, S. Bernatsky, D. Costa, K. Dasgupta, A. E. Clarke, L. Joseph, Y. St Pierre, C. A. Pineau. (2009) Application of a nomogram for exercise capacity in women with systemic lupus erythematosus. Clinical Rheumatology 28:6, 719-722
    CrossRef

  32. 32

    Lee W Jones, Neil D Eves, Mark Haykowsky, Stephen J Freedland, John R Mackey. (2009) Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. The Lancet Oncology 10:6, 598-605
    CrossRef

  33. 33

    Eran Toledo, Jonathan A. Lipton, Stafford G. Warren, Shimon Abboud, Mike Broce, Donald R. Lilly, Charles Maynard, B. Daniel Lucas, Galen S. Wagner. (2009) Detection of stress-induced myocardial ischemia from the depolarization phase of the cardiac cycle—a preliminary study. Journal of Electrocardiology 42:3, 240-247
    CrossRef

  34. 34

    Roseann M. Chesler, Nieca Goldberg, Richard A. Stein. (2009) Physiologic considerations and pragmatic issues in the design and implementation of lifetime exercise programs to prevent and treat coronary artery disease in women. Current Cardiovascular Risk Reports 3:3, 211-218
    CrossRef

  35. 35

    Sarah E. Linke, Thomas Rutledge, B. Delia Johnson, Marian B. Olson, Vera Bittner, Carol E. Cornell, Leslee J. Shaw, Wafia Eteiba, Susmita Parashar, David S. Sheps, Diane A. Vido, Suresh Mulukutla, C. Noel Bairey Merz. (2009) The Joint Impact of Smoking and Exercise Capacity on Clinical Outcomes among Women with Suspected Myocardial Ischemia: The WISE Study. Journal of Women's Health 18:4, 443-450
    CrossRef

  36. 36

    Carl J. Lavie, Randal J. Thomas, Ray W. Squires, Thomas G. Allison, Richard V. Milani. (2009) Exercise Training and Cardiac Rehabilitation in Primary and Secondary Prevention of Coronary Heart Disease. Mayo Clinic Proceedings 84:4, 373-383
    CrossRef

  37. 37

    C. J. Lavie, R. J. Thomas, R. W. Squires, T. G. Allison, R. V. Milani. (2009) Exercise Training and Cardiac Rehabilitation in Primary and Secondary Prevention of Coronary Heart Disease. Mayo Clinic Proceedings 84:4, 373-383
    CrossRef

  38. 38

    L.A. Gondoni, A.M. Titon, F. Nibbio, G. Augello, G. Caetani, A. Liuzzi. (2009) Heart rate behavior during an exercise stress test in obese patients. Nutrition, Metabolism and Cardiovascular Diseases 19:3, 170-176
    CrossRef

  39. 39

    S. Kurl, J. Sivenius, T. H. Mäkikallio, R. Rauramaa, J. A. Laukkanen. (2009) Exercise workload, cardiovascular risk factor evaluation and the risk of stroke in middle-aged men. Journal of Internal Medicine 265:2, 229-237
    CrossRef

  40. 40

    Micha T. Maeder, Peter Ammann, Thomas Münzer, Otto D. Schoch, Wolfgang Korte, Christoph Hürny, Jonathan Myers, Hans Rickli. (2009) Continuous positive airway pressure improves exercise capacity and heart rate recovery in obstructive sleep apnea. International Journal of Cardiology 132:1, 75-83
    CrossRef

  41. 41

    Lee W. Jones, Neil D. Eves, Bercedis L. Peterson, Jennifer Garst, Jeffrey Crawford, Miranda J. West, Stephanie Mabe, David Harpole, William E. Kraus, Pamela S. Douglas. (2008) Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients. Cancer 113:12, 3430-3439
    CrossRef

  42. 42

    Martha Gulati, Dina M. Sparano. (2008) Survival of the Fittest: Impact of Cardiorespiratory Fitness on Mortality, Cardiac Risk, and its Relationship with Body Mass Index in Women. Obesity Management 4:5, 222-226
    CrossRef

  43. 43

    Cheryl Bushnell. (2008) Stroke prevention in women: Challenges and opportunities. Current Atherosclerosis Reports 10:4, 347-353
    CrossRef

  44. 44

    Debbie A. Lawlor, Ashley R. Cooper, Chris Bain, George Davey Smith, Amanda Irwin, Chris Riddoch, Andy Ness. (2008) Associations of birth size and duration of breast feeding with cardiorespiratory fitness in childhood: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC). European Journal of Epidemiology 23:6, 411-422
    CrossRef

  45. 45

    Araceli Boraita Pérez. (2008) Ejercicio, piedra angular de la prevención cardiovascular. Revista Española de Cardiología 61:5, 514-528
    CrossRef

  46. 46

    Kristin M. Houghton, Lori B. Tucker, James E. Potts, Donald C. Mckenzie. (2008) Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arthritis & Rheumatism 59:4, 537-545
    CrossRef

  47. 47

    Panteleimon Ekkekakis, Jennifer Thome, Steven J. Petruzzello, Eric E. Hall. (2008) The Preference for and Tolerance of the Intensity of Exercise Questionnaire: A psychometric evaluation among college women. Journal of Sports Sciences 26:5, 499-510
    CrossRef

  48. 48

    Borys Surawicz, Morton Tavel. 2008. Stress Test. , 221-255.
    CrossRef

  49. 49

    Xuemei Sui, James N. Laditka, James W. Hardin, Steven N. Blair. (2007) Estimated Functional Capacity Predicts Mortality in Older Adults. Journal of the American Geriatrics Society 55:12, 1940-1947
    CrossRef

  50. 50

    Esther S.H. Kim, Hemant Ishwaran, Eugene Blackstone, Michael S. Lauer. (2007) External Prognostic Validations and Comparisons of Age- and Gender-Adjusted Exercise Capacity Predictions. Journal of the American College of Cardiology 50:19, 1867-1875
    CrossRef

  51. 51

    Amgad N. Makaryus, Leslee J. Shaw, Jennifer H. Mieres. (2007) Diagnostic Strategies for Heart Disease in Women. Cardiology in Review 15:6, 279-287
    CrossRef

  52. 52

    Tim Takken, Marieke HP Tacken, A Christian Blank, Erik H Hulzebos, Jan LM Strengers, Paul JM Helders. (2007) Exercise limitation in patients with Fontan circulation: a review. Journal of Cardiovascular Medicine 8:10, 775-781
    CrossRef

  53. 53

    Nana Valeur, Peter Clemmensen, Peer Grande, Kari Saunamäki. (2007) Prognostic Evaluation by Clinical Exercise Test Scores in Patients Treated With Primary Percutaneous Coronary Intervention or Fibrinolysis for Acute Myocardial Infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study). The American Journal of Cardiology 100:7, 1074-1080
    CrossRef

  54. 54

    Samuele M. Marcora, Francesco Casanova, Matthew B. Fortes, Peter J. Maddison. (2007) Validity and reliability of the Siconolfi Step Test for assessment of physical fitness in patients with systemic lupus erythematosus. Arthritis & Rheumatism 57:6, 1007-1011
    CrossRef

  55. 55

    J. A. Laukkanen, R. Rauramaa, J. T. Salonen, S. Kurl. (2007) The predictive value of cardiorespiratory fitness combined with coronary risk evaluation and the risk of cardiovascular and all-cause death. Journal of Internal Medicine 262:2, 263-272
    CrossRef

  56. 56

    PANTELEIMON EKKEKAKIS, ERIK LIND, ERIC E. HALL, STEVEN J. PETRUZZELLO. (2007) Can Self-Reported Tolerance of Exercise Intensity Play a Role in Exercise Testing?. Medicine & Science in Sports & Exercise 39:7, 1193-1199
    CrossRef

  57. 57

    Mardi Gomberg-Maitland, Dezheng Huo, Raymond L. Benza, Vallerie V. McLaughlin, Victor F. Tapson, Robyn J. Barst. (2007) Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation 26:7, 732-738
    CrossRef

  58. 58

    Jonatan R. Ruiz, Francisco B. Ortega, Dirk Meusel, Michael Sjöström. (2007) Traditional and novel cardiovascular risk factors in school-aged children: A call for the further development of public health strategies with emphasis on fitness. Journal of Public Health 15:3, 171-177
    CrossRef

  59. 59

    John P. Higgins, Johanna A. Higgins. (2007) Electrocardiographic exercise stress testing: An update beyond the ST segment. International Journal of Cardiology 116:3, 285-299
    CrossRef

  60. 60

    Antonio Cabrera de León, María Del C. Rodríguez-Pérez, Luis M. Rodríguez-Benjumeda, Basilio Anía-Lafuente, Buenaventura Brito-Díaz, Mercedes Muros de Fuentes, Delia Almeida-González, Marta Batista-Medina, Armando Aguirre-Jaime. (2007) Sedentarismo: tiempo de ocio activo frente a porcentaje del gasto energético. Revista Española de Cardiología 60:3, 244-250
    CrossRef

  61. 61

    Fabian Lötscher, Tobias Löffel, Roger Steiner, Michael Vogt, Stephan Klossner, Albrecht Popp, Kurt Lippuner, Hans Hoppeler, Christoph Däpp. (2007) Biologically relevant sex differences for fitness-related parameters in active octogenarians. European Journal of Applied Physiology 99:5, 533-540
    CrossRef

  62. 62

    Susan E. Brien, Ian Janssen, Peter T. Katzmarzyk. (2007) Cardiorespiratory fitness and metabolic syndrome: US National Health and Nutrition Examination Survey 1999–2002. Applied Physiology, Nutrition, and Metabolism 32:1, 143-147
    CrossRef

  63. 63

    Nanette K. Wenger, Bernard Chaitman, George W. Vetrovec. (2007) Gender Comparison of Efficacy and Safety of Ranolazine for Chronic Angina Pectoris in Four Randomized Clinical Trials. The American Journal of Cardiology 99:1, 11-18
    CrossRef

  64. 64

    Antonio Cabrera de León, María de la C. Rodríguez-Pérez, Luis M. Rodríguez-Benjumeda, Basilio Anía-Lafuente, Buenaventura Brito-Díaz, Mercedes Muros de Fuentes, Delia Almeida-González, Marta Batista-Medina, Armando Aguirre-Jaime. (2007) Sedentary Lifestyle: Physical Activity Duration Versus Percentage of Energy Expenditure. Revista Española de Cardiología (English Edition) 60:3, 244-250
    CrossRef

  65. 65

    S S Kohles, K N Gregorczyk, T C Phillips, L T Brody, J F Orwin, R Vanderby. (2007) Concentric and eccentric shoulder rehabilitation biomechanics. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 221:3, 237-249
    CrossRef

  66. 66

    V. Novak, K. Hu, M. Vyas, L. A. Lipsitz. (2007) Cardiolocomotor Coupling in Young and Elderly People. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62:1, 86-92
    CrossRef

  67. 67

    Sandra D??Amore, Samia Mora. (2006) Gender-Specific Prediction of Cardiac Disease. Cardiology in Review 14:6, 281-285
    CrossRef

  68. 68

    Joseph Abdulnour, Bernard Pinet, Pierre Boulay, Eric Doucet, Martin Brochu, R??mi Rabasa-Lhoret, Denis Prud'homme. (2006) Determinants of Percentage of Predicted Exercise Capacity in Premenopausal Women. Medicine & Science in Sports & Exercise 38:Suppl 1, S5
    CrossRef

  69. 69

    Brent M. Graves, Mac Strand, Alec R. Lindsay. (2006) A reassessment of sexual dimorphism in human senescence: Theory, evidence, and causation. American Journal of Human Biology 18:2, 161-168
    CrossRef

  70. 70

    Carlos Bernal-Mizrachi, Clay F Semenkovich. (2006) Fast predators or fast food, the fit still survive. Nature Medicine 12:1, 46-47
    CrossRef

  71. 71

    Christopher Sibley, Roger S. Blumenthal, C. Noel Bairey Merz, Lori Mosca. (2006) Commentary : Limitations of Current Cardiovascular Disease Risk Assessment Strategies in Women. Journal of Women's Health 15:1, 54-56
    CrossRef

  72. 72

    W FRISHMAN. (2006) Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women's Health Initiative Observational StudyHoward BV, Kuller L, Langer R, et al (MedStar Research Inst, Washington, DC; Univ of Pittsburgh, Pa; Univ of California San Diego, La Jolla; et al) Circulation 111:1462–1470, 2005§. Yearbook of Medicine 2006, 305-306
    CrossRef

  73. 73

    (2005) Nomogram for Exercise Capacity in Women. New England Journal of Medicine 353:21, 2301-2303
    Full Text

  74. 74

    Donna J. Drown. (2005) Exercise Capacity in Women: A New Measure of Survival?. Progress in Cardiovascular Nursing 20:4, 183-183
    CrossRef

  75. 75

    Kraus, William E., Douglas, Pamela S., . (2005) Where Does Fitness Fit In?. New England Journal of Medicine 353:5, 517-519
    Full Text

Letters